Podcast appearances and mentions of Charlie Kelly

An episode that explores autistic and neurodivergent representation in The Big Bang Theory and It's Always Sunny in Philadelphia. From Sheldon's neurotypical framing to Charlie Kelly's proudly autistic chaos, we break down what hits, what misses, and why it matters.Here's what's in store for today's episode: * In today's episode, we're diving into It's Always Sunny in Philadelphia and how it nails autistic representation—unlike The Big Bang Theory, which mostly reflects a neurotypical perspective.* We start by breaking down what The Big Bang Theory got right—and wrong—about autism, touching on Young Sheldon and the dynamic between Sheldon and Amy.* After that, we dive into how It's Always Sunny in Philadelphia is actually deeply autism-centric, even if it's not explicitly framed that way.* Then, we dive into how It's Always Sunny in Philadelphia is deeply autism-centric—thanks in large part to Charlie Kelly, who is explicitly autistic and gives the show its neurodivergent heart.* We also explore how the writers of It's Always Sunny approach the show from a neurodivergent lens—crafting characters who consistently misunderstand the world around them in ways that feel deeply relatable to autistic viewers.* Our hosts get into all the autistic tendencies throughout the show—from Sweet Dee, Dennis, and Charlie's unique quirks to Charlie himself, who has openly identified as autistic multiple times.* We also talk about how the humor in It's Always Sunny is specifically tailored to an autistic audience and sense of humor—sharp, absurd, and rooted in social misunderstandings.* Matt and Angela also discuss the concept of autistic integrity and how it shows up both in It's Always Sunny and in the core values of this podcast.* Sometimes we have to play the game of capitalism just to get by—but as long as you've got your crew of fellow weirdos to lean on, you'll make it through.“It's representation, but at what cost? We don't have a seat at the table. There is a picture on the table of a caricature of an autistic person. And then everyone else talking about how weird they are.” - Matt“The impetus behind It's Always Sunny was not, ‘hey, let's make a marketable show and sell it and have lots of airtime and get in the top 20 or whatever.' They're like, ‘hey, you know what would be funny? If we did our own thing with a low-res video recorder.” - Matt“They are very, very socially minded. They're very, very self conscious about these things, which is the autistic way. They do things in the way that they do it because they think it's the right thing to do. Whenever they see an issue, they want to call it out on the show. So they do it in the most blatant way possible so that the people watching it will be like, ‘hey, that's an issue.” - MattDid you love this episode? We took a deep dive into autistic representation in pop culture—comparing The Big Bang Theory and It's Always Sunny in Philadelphia. From Sheldon and Amy's dynamic to Charlie Kelly's openly autistic identity, we unpack how neurodivergent humor, character quirks, and autistic integrity show up on screen. We also explore how Sunny nails an autistic lens through its writing, jokes, and chaotic logic. Join the convo with #AutisticCultureCatch!Related Episodes:Community is AutisticFollow us on InstagramFind us on Apple Podcasts and SpotifyLearn more about Matt at Matt Lowry, LPPJoin Matt's Autistic Connections Facebook GroupLearn more about Angela at AngelaKingdon.com Angela's social media: Twitter and TikTokOur Autism-affirming merch shop This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.autisticculturepodcast.com/subscribe

Join Rick Boothby of Acumen Financial as we discuss Supplemental Executive Retirement Benefits. Join us as we discuss using SERPS to hire and retain your high-value employees, as well as some of the pushback you may get from your internal teams as you implement or modify your SERP program.If you would like to schedule a call with Rick Boothby to further explore SERPS for your organization, please send an email to Mark Axmacher, Acumen Financial Advantage Business Development Manager at maxmacher@acumenfa.com.Send us a textPresented by Remedy ConsultingTechnology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

“Bear of Beeftown Adventure” (April 7, 2024) About a hundred episodes later, this podcast is pleased to report that The Great North got even gayer with the season four addition of Aunt Dirt, voiced by Jane Lynch. She's been living in a bunker for sixty years and in this episode she learns about what it means to be a lesbian in the 2020s. Listen to our previous episode about The Great North and our interview with Charlie Kelly, who wrote both the episodes we've covered. We have episode transcripts courtesy of Sarah Neal. Our logo was designed by Rob Wilson. This episode's art was designed by Ian O'Phelan.

Join Jack Kasel from Anthony Cole Training Group as we explore effective strategies to analyze and enhance your commercial lending team. We delve into diagnostic tools, peer reviews, and the essential training required by your senior managers to drive improved results. This episode is a must-listen for anyone looking to elevate their commercial lending operations.Send us a textPresented by Remedy ConsultingTechnology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Rescatamos el audio del último vídeo de nuestro canal #ClassicMTB para contaros un episodio fundamental y fundacional para la historia del Mountain Bike. Se trata de las míticas carreras Repack que empezaron a celebrarse en California, en el condado de Marin, en la década de los 70. Es la historia de pioneros como Charlie Kelly, Gary Fisher, Alex Bonds, Tom Ritchey, Joe Breeze o Mike Sinyard. Pero conocer todo esto no sería posible si no fuera por personas e instituciones como Wende Cragg, el Marin Museum of Bicycling o la "biblia" escrita por Charlie Kelly: Fat Tyre Flyer. Vídeo completo en nuestro canal de YouTube: https://youtu.be/xCnOuHAMRSU?si=EsPzMhaaMng0kVmj

Next Generation core banking systems are going to change the way that community bankers think about open banking.   Are the promises made by “next generation” core systems, which intend to replace the legacy core offerings by the Big Three providers (Fiserv, FIS and Jack Henry), coming to fruition? Is it time for Community Banks to migrate to a Next Gen core system?  Join Charlie Kelly, Partner at Remedy Consulting, as we discuss Next Gen cores.   Send us a textPresented by Remedy ConsultingTechnology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Kip Weissman from Luse Gorman as we discuss what happened in community bank acquisitions in 2024, and the outlook for M&A activity in 2025. We discuss major headwinds and tailwinds that may affect bank buyers and sellers in the near future.Send us a textPresented by Remedy ConsultingTechnology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

The Philadelphia Flyers closed out 2024 with a decisive win over the San Jose Sharks and Macklin Celebrini.John Tortorella rolled 4 lines against the lowly Sharks, and Philly stymied San Jose for most of the night, limiting their offensive opportunities and taking advantage of a healthy shot differential.Bill, Charlie & Kelly ring in the new year breaking down the Orange & Black‘s victory and discussing the Calder Trophy favorites.

Join Scott Hildenbrand from Piper Sandler as we discuss the recent Fed moves, the yield curve, unrealized losses, and the US elections and strategies that banks and credit unions are making to improve their investment portfolios.Send us a textPresented by Remedy ConsultingTechnology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Motherhood is a doggone nightmare in the new film from Marielle Heller. This week, the writer director of movies like The Diary of a Teenage Girl, Can You Ever Forgive Me? and A Beautiful Day in the Neighborhood returns to cinemas with one of the more surreal-sounding offerings of the year – Nightbitch, a drama in which Amy Adams plays a parent by day and a dog by night. If you weren't already familiar with the 2021 Rachel Yoder novel on which it's based, you'd be forgiven for thinking that this film is a frantic comedy, or possibly the mad fever dream of Charlie Kelly from It's Always Sunny In Philadelphia – a character with his fair share of hound-based ideas for movies. But no, Nightbitch is something else – an affecting, magical realist tale of a woman pushed over a feral brink by the physical and societal demands placed on women, that needs to be seen to be believed.On today's episode, Marielle joins Al Horner to break down in spoiler-filled detail this remarkable film. We get into why the realities of birth – the body horror of it all – are so under-acknowledged in pop culture. We talk about why, after the gentleness of films like A Beautiful Day In The Neighbourhood, Marielle fled in the opposite direction, towards this anarchic scream of a story. And you'll also discover the truth behind some of the movie's more ambiguous, unresolved questions: such as, are the women that Adams character befriends also secretly dogs?Script Apart is hosted by Al Horner and produced by Kamil Dymek. Follow us on Instagram, or email us on thescriptapartpodcast@gmail.com.Support for this episode comes from ScreenCraft, Final Draft and WeScreenplay.To get ad-free episodes and exclusive content, join us on Patreon.Support the show

As we digest the results of Election Day, I thought Beacon residents might want to take a walk down memory lane to review what happened 35 years ago, in 1989. I co-chaired the Republican campaign in Beacon that year, and the results of the November election were groundbreaking. All five Democratic City Council members, including Mayor Jim Fredericks, were swept from office by Clara Lou Gould and her four Republican or independent running mates: Dr. Robert Frankel, Al Romanelli, John McElduff and Joseph Guarneri Jr. In addition, by a 58 percent to 42 percent margin, voters approved a change in how the city was run to a "strong mayor" structure. Instead of the five council members being elected citywide (i.e., the commissioners of public works, public safety, finance and accounts, plus the mayor), the seats would represent each of the four wards, supplemented by two council members elected citywide ("at-large") and the mayor. That is the system the city uses today. Notably, Poughkeepsie amended its charter shortly after Beacon but kept the mayor off the council, which I thought was a mistake. If you asked each mayor who has served in Beacon post-charter revision, I suspect they would agree that it is important not to create more distance between the executive and legislative branches. Although Beacon in 1989 was one of only a few municipalities in New York state that still operated with commissioners, there were many heated discussions about changing the charter. I co-chaired a group with my friend Charlie Kelly that supported the change. Charlie challenged Mayor Fredericks in the Democratic primary but was narrowly defeated. Tony Borrero was the only member of Kelly's coalition to oust an incumbent "old guard" council member in the Democratic primary, but he lost to McElduff in the general election. The charter change approved by voters radically changed Beacon's government. All administrative authority shifted to the mayor, who was empowered to appoint a city administrator to run day-to-day affairs. The mayor could also remove the administrator. The six-member council was given legislative and policy-making duties and approved appointments such as the city administrator, the city attorney (a position I held from 1990 to 1999), members of the planning and zoning boards and various other committees. The mayor chaired council meetings. Although approved in 1989, none of these changes took effect until after the 1991 election, when voters filled the six council seats and elected a mayor. (The Republicans swept that election, as well.) Mayor Gould would serve for the next 18 years. Joseph Braun, the city's first administrator, also held his position for 18 years. That sort of tenure was unusual at the time. One argument against the reforms was that Beacon was too small to keep the same city administrator for any length of time. I suspect that few current residents are aware of what transpired 35 years ago during that historic election, but I believe most would agree that the results benefited everyone who has lived and worked in Beacon since 1989 and for many years to come.

Join Chris Davis, SVP at River Bank as we discuss BaaS and the implications of the Synapse, a program manager middleman in the Banking as a Service space. If you have considered hosting fintech relationships at your financial institution this is a very informative episode.Send us a textPresented by Remedy ConsultingTechnology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Renee Perez, National Director of Sales-Financial Crimes for Jack Henry, as we discuss innovative new areas where fraudsters are using AI to commit fraud, and then a discussion on areas where AI is being used to fight back.Whitepaper:https://fedpaymentsimprovement.org/strategic-initiatives/payments-security/scams/Send us a textPresented by Remedy ConsultingTechnology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Lynne Marlor, Co-Founder, of Women in Digital Assets, US Head of Partnerships/Memberships, to discuss the Global Blockchain Business Council and Central Bank Digital Currencies. She differentiates a stablecoin from a CBDC and the risks associated with each one. Lynne then talks about other countries that have adopted the CBDC and the pros and cons. Lastly, we check in on the US mindset and when she thinks we might adopt a version of a CBDC and why.Send us a textFor more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Rafael DeLeon, SVP of Industry Engagement at Ncontracts, as we discuss the US Supreme Court decision that ruled the Chevron case regarding government agency overreach. While overruling Chevron may seem like it is all positive for financial institutions, there may be other sides of the argument to consider for bankers.Send us a textFor more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Adam Keifer, VP of Sales for Fiserv, as we discuss the opportunity that Merchant Services may provide for financial institutions for non-interest income with the right commercial customer base.  We discuss the industry and what it might mean for your relationships with your commercial customers.Send us a Text Message.Presented by Remedy Consulting Technology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Rich Carty hosts, interviewing Charlie Kelly, Partner at Remedy Consulting as we walk through the last several years of the BankTalk Podcast. We discussed the most downloaded episodes and things we learned along the way about how to provide the best episodes for our listeners.Send us a Text Message.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Ken Laroe, CEO and Co-Founder of Climate First Bank, as he discusses how a social strategy and focus on the environment helped Climate First grow from a Denovo to a bank with $600M in assets in just a few years. Presented by Remedy Consulting Technology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Denny Howell, Co-Founder and COO of Mahalo Banking, as we discuss the value of application customization for the neurodiverse population, which makes up an average of 20% of a credit union's customer base.   Learn the innovative techniques that are being used to recruit this group of people.Presented by Remedy Consulting Technology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

We welcome team Wild Sheep Foundation to the podcast to talk Auction Permits and the controversy around them. We bring Gray Thornton, President and CEO of the Wild Sheep Foundation along with WSF Treasurer Charlie Kelly on to discuss recent developments with these permits. Gray and Charlie are at the coal face on the auction permit front.Recently Arizona cancelled their Desert Bighorn Sheep permit. With Charlie heavily involved with the state of Arizona he has a lot of perspective to share on the complexities and what is happening in Arizona. Talk is Sheep is brought to you by our Title Sponsor, MTNTOUGH Fitness Labs.We partnered with MTNTOUGH Fitness Lab to help get you in shape and mentally stronger. Whether you are a veteran hunter or just starting, the MTNTOUGH app will take you to the next level. We've personally trained using the MTNTOUGH programs and we believe in it so much that we want to give you 6 weeks for free using code: SHEEPBC. Visit: http://lab.mtntough.com/checkout/subscribe/purchase?code=sheepbc&plan=monthlyTalk is Sheep is the Official Podcast of the Wild Sheep Society of BC. The official sponsor of the Wild Sheep Society of BC is SITKA Gear and our Conservation Partners - Frontiersmen Gear, Gunwerks, OnX Maps, Precision Optics, Schnee's, Stone Glacier, Wild TV, YETI and Zeiss.

Join Phil Buffington of the law firm Balch and Bingham, as we discuss some proactive techniques that forward-looking banks employ with their shareholders to ensure that the Board of Directors doesn't run into unexpected shareholder surprises.Presented by Remedy Consulting Technology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Peter Wilder, Manager of the bank practice at the law firm of Godfrey and Kahn, as we discuss some of the complexities and opportunities of family-owned banks. From tax consequences and estate planning to other scenarios, this podcast will show why being proactive as a family owner makes sense.Presented by Remedy Consulting Technology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Peter Tapling, Managing Director of PTap Advisory, as we discuss the pending rulemaking on Section 1033 of the Dodd-Frank legislation.  The rulemaking, at a high level, has some implications of truly Open Banking, which has been a challenge for most core providers and their customers. Presented by Remedy Consulting Technology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Alex Shvarts, CEO of FundKite, as we discuss one possible source of funding for businesses rejected for traditional bank financing.  When FICO Scores are not enough to obtain a traditional loan, revenue-based-funding offers alternatives to businesses.Presented by Remedy Consulting Technology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Sean Carter, President and CEO of NEACH, as we discuss the ACH and Payments ecosystem.  We discuss fraud prevention, cyber insurance, and the Fed Fraud Classifier in this episode as well. Presented by Remedy Consulting Technology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join us as we speak with Derek Szot, Managing Director at Piper Sandler, as we discuss subordinated debt for credit unions.    Learn why subordinated debt has been a much hotter topic for credit unions than it has for banks over the past 18 months.Contact Derek at derek.szot@psc.com.Presented by Remedy Consulting Technology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join us as we speak with Brendan Clegg, Partner at Luse Gorman about the types of issues that could lead to an enforcement action from the federal banking agencies. We cover the different types of enforcement actions, the ways that an enforcement action can develop, whether directors and officers can be subject to personal actions, common issues that trip up banks and their leadership, and other topics relevant to the bank enforcement process. Contact Brendan at bclegg@luselaw.com. Presented by Remedy Consulting Technology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join us as we speak with Becca Kruse and Lance Noggle from the ICBA about some of the pending updates to the Durbin Amendment to the Dodd-Frank Act. Learn about Interchange revenue and expenses and whether the latest updates will have a net impact on your monthly earnings.Presented by Remedy Consulting Technology Contract Negotiation & System Assessments, T&C Improvements, and FI Strategic Planning.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join us as we speak with Scott Hildenbrand, Head of Piper Sandler Financial Strategies, about how community financial institutions are morphing to improve liquidity.  We then discuss how the higher price of purchasing deposits will likely affect loan volume in the foreseeable future.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Core providers have been touting their advances in integrating to third parties through their “open” core platforms.  We ask Charles Potts, Chief Innovation Officer at the ICBA to provide some insights into the “openness” of the major core vendors.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

The sex trafficking victims of Jeffrey Epstein recently reached a large settlement with Epstein's former bankers, JP Morgan and Deutsche Bank, roughly $365M. Join Ariel Gutierrez, Program Director for the Financial Crimes Risk Management product at Fiserv, as we discuss the potential liability implications for community financial institutions. For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

With the release of Faster Payments, we decided to have a discussion with Tede Forman, President of Payment Solutions at Jack Henry on the Payment Rails, what they are, and how they differ.  Then we spend a few minutes discussing the opportunity and threat to community financial institutions related to  Faster Payments. For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

CEOs at community financial institutions continue to ask for ideas to improve liquidity and income in these changing market conditions, and Receivables Financing checks both boxes.  Join Erik Trumpower, EVP of Capstone Banktech, as we discuss the risk and rewards of this sector, and discuss some ideas for administering a program at a community FI.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Charlie Kelly, Partner at Remedy Consulting, as we discuss core banking systems and whether your financial institution is on the right core to improve efficiency and drive sales. If you are considering a change in your core system, what should you know ahead of time and are you asking the right questions? https://www.remedyconsult.net/whitepaper/https://fi-navigator.com/ For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Rob Foxx from FIPCO as we discuss Cybersecurity threats and some things you can do to avoid them.  What does your cyber insurance cover and what do cyber claims look like?For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Let's talk about the PGA, twitter pictures, and preseason rankings...Charlie Kelly has sisters he's never mentioned for 15 seasons.Benzema's scary, scary contract.The PGA... Jay Monahan... all-time scumbag.The NCAA has changed the ruling on "sliding in" charge calls.Andre Curbello dipped off the scene when Rick Pitino rolled into St. John's. Michigan has added some Frontcourt production.Rutgers is taking Paul Mulcahey's departure and self-entitlement of "New Jersey's PG" too lightly. New Jersey's PG on Kentucky?Cam Spencer joining UConnThe Penn State is adding penBig 12 Mexico? Time to act on Big Ten Europe.Indiana Baseball Finale recapTeryn Kern, gone.TJD's workout with the Pacers went swimmingly, because of course it did.Oh Yeah Race!Simeon Wilcher part of the Great Heel Migration (some are calling it that).Jaeden Mustaf visited this last weekend.The Squad is hitting the bench. Welcome James Goodis.Shouts to LC Norton for the PAYTON Sparks story. (I'm sorry I said Jordan at first... The only Sparks name I knew prior to this middle linebacker who has to be 6'11 and a half).Indiana on site in Colorado Springs.Gabe Cupps is officially strong enough.Fischers thinking their Carmel...@bigbantersportsWhat the lack of a preseason ranking means for the potential season in store... (Not Loser Talk)Hoosier History Hit: Alan Henderson; sources: Indiana Basketball Hall of fame and indianahq.com.Follow me on twitter @oftendaunted. If you are interested in providing any feedback that can help improve the show please send them my way at oftendaunted@gmail.com. If you wanted to submit a voicemail take or ask a question on the show, leave one at (260) 267-5460. not an insider. just a fan. Not affiliated with Indiana University, just educated by them.

Join Cal Roberson of Integris as we discuss the need for technology expertise on community bank Boards of Directors. What are the risks of having a less-than-tech-savvy individual heading up your technology sub-committee? Join us to find out. caltech.com/ For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Scott Hildenbrand of Piper Sandler as we discuss a few topics that your board and management teams may be asking in light of the SVB failure. How are you approaching uninsured depositors, and are you utilizing all investment options are a couple of the topics we cover in this episode. For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Tyler Barron of Encapture as we discuss additional regulatory requirements that are about to be added to Dodd-Frank. For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Ever wonder why one bank is willing to pay $500 for a new customer and another is offering only $150? Join Supreet Singh, CEO of Finlytica, as we discuss the financial value of a customer. What revenue streams are important, how to think about cost-per-customer, and other interesting considerations for new customer acquisition. For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

The availability and quality of cancer care varies in different parts of the globe. Some locations find it difficult to have proper equipment, access to medications or even trained staff on hand. In this ASCO Education podcast we look how a group of doctors are sharing their skills and experience to set up training programs to help improve outcomes for patients with cancer in Kenya. Our guests will explore the creation of a pediatric oncology fellowship program in Kenya (11:48), how a young doctor found herself interested in improving global health (14:30), and discuss lessons learned that are applicable to health care in the United States (21:07).  Speaker Disclosures Dr. David Johnson: Consulting or Advisory Role – Merck, Pfizer, Aileron Therapeutics, Boston University Dr. Patrick Loehrer: Research Funding – Novartis, Lilly Foundation, Taiho Pharmaceutical Dr. Terry Vik: Research Funding Takeda, Bristol Myers Squibb Foundation Dr. Jennifer Morgan: None Resources: Podcast: Oncology, Etc. - Dr. Miriam Mutebi on Improving Cancer Care in Africa Podcast: Oncology, Etc. – Global Cancer Policy Leader Dr. Richard Sullivan (Part 1) Podcast: Oncology, Etc. – Global Cancer Policy Leader Dr. Richard Sullivan Part 2 If you liked this episode, please follow the show. To explore other educational content, including courses, visit education.asco.org. Contact us at education@asco.org. TRANSCRIPT Disclosures for this podcast are listed in the podcast page. Dave Johnson: Welcome, everyone, to a special edition of Oncology, Etc., an oncology educational podcast designed to introduce our listeners to interesting people and topics in and outside the world of Oncology. Today's guest is my co-host, Dr. Pat Loehrer, who is the Joseph and Jackie Cusick Professor of Oncology and Distinguished Professor of Medicine at Indiana University, where he serves as the Director of Global Health and Health Equity. Pat is the Director Emeritus of the Indiana University Simon Comprehensive Cancer Center. Pat has many different accomplishments, and I could spend the next hour listing all of those, but I just want to point out, as many of you know, he is the founder of what formerly was known as the Hoosier Oncology Group, one of the prototypes of community-academic partnerships which have been hugely successful over the years.  He's also the founding director of the Academic Model for Providing Access to Healthcare Oncology Program, which has grown rather dramatically over the last 17 years. This includes the establishment of fellowship programs in GYN oncology, pediatric oncology, and medical oncology through the Moi University School of Medicine in Kenya. Through its partnership with the Moi Teaching and Referral Hospital, over 8000 cancer patients a year are seen, and over 120,000 women from western Kenya have been screened for breast and cervical cancer in the past five years. Pat is also the co-PI of the U-54 grant that focuses on longitudinal HPV screening of women in East Africa. He currently serves as a Senior Consultant of the NCI Cancer for Global Health.  So, Pat, welcome. We have with us today two special guests as well that I will ask Pat to introduce to you. Pat Loehrer: Dave, thanks for the very kind introduction. I'm so pleased today to have my colleagues who are working diligently with us in Kenya. The first is Terry Vik, who is Professor of Pediatrics here at Indiana University and at Riley Hospital. He's been the Director of the Fellowship Program and the Pediatric Hematology-Oncology Program and Director of the Childhood Cancer Survivor Program. He got his medical degree at Johns Hopkins and did his residency at UCLA and his fellowship at Dana-Farber. And he's been, for the last 10 to 15 years, been one of my co-partners in terms of developing our work in Kenya, focusing on the pediatric population, where he helps spearhead the first pediatric oncology fellowship in the country.  And then joining us also is Dr. Jennifer Morgan. Jenny is a new faculty member with us at Indiana University as an Assistant Professor. She, I think, has 16 state championship medals for track and field in high school. I've never met an athlete like that in the past. She ended up going to Northwestern Medical School. She spent time in Rwanda with Partners in Health, and through that, eventually got interested in oncology, where she completed her fellowship at University of North Carolina and has spent a lot of her time in Malawi doing breast cancer research. I don't know of anyone who has spent as much time at such a young age in global oncology.  Dave Johnson: So Pat, obviously, you and I have talked a lot over the years about your work in Kenya, but our listeners may not know about Eldoret. Maybe you can tell us a little bit about the history of the relationship between your institution and that in Kenya. Pat Loehrer: It's really a remarkable story. About 30 some odd years ago, Joe Mamlin and Bob Einterz, and Charlie Kelly decided they wanted to do a partnership in Global Health. And they looked around the world and looked at Nepal and looked at Mexico, and they fell upon Eldoret, which was in Western Kenya. They had the birth of a brand new medical school there, and this partnership developed. In the midst of this came the HIV/AIDS pandemic. And these gentlemen worked with their colleagues in Kenya to develop one of the most impressive programs in the world focused on population health and dealing with the AIDS pandemic. They called it the Academic Model for Prevention and Treatment of HIV/AIDS or AMPATH, and their success has been modeled in many other places. They have many different institutions from North America and Europe that have gone there to serve Western Kenya, which has a catchment area of about 25 million people.  About 15 to 20 years ago, I visited AMPATH, and what they had done with HIV/AIDS was extraordinary. But what we were seeing there in cancer was heartbreaking. It reminded us, Dave, as you remember back in the ‘60s and ‘70s with people coming in with advanced cancers of the head and neck and breast cancers that were untreated. And in addition, we saw these young kids with Burkitt's Lymphomas with huge masses out of their jaws. And seeing that and knowing what was possible, what we saw in the States and what seemed to be impossible in Kenya, spurred me on, as well as a number of other people, to get involved. And so, we have built up this program over the last 15 and 20 years, and I think it's one of the most successful models of global oncology that's in existence.  Dave Johnson: That's awesome. Terry, tell us a little bit about your involvement with the program at Moi University.  Terry Vik: Sure. So, I took an unusual path to get to Eldoret because I started off in work in signal transduction and protein kinases, then morphed into phase I studies of kinase inhibitors that was happening in the early 2000s. But by the end of the decade, Pat was beginning to establish oncology programs in Kenya. And because half the population is children and there were lots of childhood cancers, and many of them can be curable, he mildly twisted my arm to go with him to set up pediatric oncology in Kenya. And through his help and Matt Strother, who is a faculty member on the ground, establishing that, I first went in 2010 just to see how things were running and to see all the things that Pat had recognized as far as things that needed to be done to make Eldoret a center for cancer care.   And so, the last 13 years now, I've been working, going anywhere from one to four times a year to Kenya, mainly helping the Kenyans to develop their medical care system. Not so much seeing patients or taking care of patients, other than talking about best practices and how we do things in the US that can be readily translated to what's going on in Kenya. And so, we've been able to establish a database, keep track of our patients in pediatric oncology, recognize that lots of kids are not coming into care, not being diagnosed. There's a huge gap between numbers who you would expect to have childhood cancer versus the numbers actually coming to the hospital. As the only pediatric treatment center for a catchment area of 25 million, half of whom are under the age of 20, we should be seeing a lot of kids with cancer, but we are probably only seeing 10% of what we would expect.  So, myself, many of my colleagues from Indiana University, as well as colleagues from the Netherlands Princess Maxima Hospital for Pediatric Cancer, we've been partnering for these past 13 years to train Kenyans to recognize cancer, to have treatment protocols that are adapted for the capabilities in Kenya, and now finally starting to show real progress in survival for childhood cancer in Kenya, both in leukemias, lymphomas, and solid tumors, with a fair number of publications in Wilms tumor and Burkitt lymphoma and acute lymphoblastic leukemia. So, it's been really heartening, I think.  I tell people that the reason I go to Kenya studying signal transduction and protein kinase inhibitors in pediatric cancer, I can maybe save a couple of kids over a career by that kind of work. But going to Kenya to show people how to find and treat kids with leukemia, I'm literally seeing the impact of hundreds of kids who are alive today that wouldn't be alive otherwise. So, that's really been the success of pediatric oncology there. Dave Johnson: Is the spectrum of childhood cancer in Kenya reflective of what we see in the States, or are there some differences? Pat Loehrer: It really is surprisingly similar. I think the only thing that– Well, two things that are more common in Kenya because of the so-called ‘malaria belt' and the association with Burkitt Lymphoma, there's a fair number of kids with Burkitt's Lymphoma there. Although, as mosquito control and malaria control has improved, actually, the numbers of cases of Burkitt's have been dropping, and a lot of cancers were sort of hidden, not recognized as leukemia or not recognized as other lymphomas. Just because if Burkitt's is endemic, then every swelling is Burkitt's. And I think that's been shown by looking at pathology retrospectively to say a lot of what they thought was Burkitt's was maybe not necessarily Burkitt's. And then nasopharyngeal carcinoma with Epstein-Barr virus prevalence also is a little bit more common than I'm used to seeing, but otherwise, the spectrum of cancers are pretty similar. So, it's heartening to know that we've been treating childhood cancers with simple medicines, generic medicines, for 50 years in the US. And so I like to tell people, I just want to get us up to the ‘90s, maybe the 2000s in Kenya, and that will really improve the survival quite a bit. Dave Johnson: You mentioned that there were adjustments that you were making in the therapies. Could you give us some examples of what you're talking about? Terry Vik: The biggest adjustments are that the ability to give blood product support, transfusions of platelets is somewhat limited. So, for instance, our ability to treat acute myeloid leukemia, which is heavily dependent on intensive myelosuppressive chemotherapy, we're not so good at that yet because we don't have the support for blood products. Similarly, the recognition and treatment of infections in patients is somewhat limited. Yet, just the cost of doing blood cultures, getting results, we actually have the antibiotics to treat them, but figuring out that there actually is an infection, and we're just beginning to look at resistance patterns in bacteria in Kenya because I think that's an indiscriminate use of antibiotics. In Kenya, there are a lot of resistant organisms that are being identified, and so figuring out how best to manage those are the two biggest things. But now, in Eldoret, we have two linear accelerators that can give contemporary radiation therapy to kids who need it. We have pediatric surgeons who can resect large abdominal tumors. We have orthopedic surgeons and neurosurgeons to assist. All those things are in place in the last three to five years. So, really, the ability to support patients through intensive chemotherapy is still one of the last things that we're working diligently on improving. Dave Johnson: So one thing that I've read that you've done is you're involved heavily in the creation of a pediatric oncology fellowship program. If I read it correctly, it's a faculty of one; is that correct? Terry Vik: Well, now that two have just graduated, it's a faculty of three, plus some guest lecturers. So I feel quite good about that.  Dave Johnson: So tell us about that. That must have been quite the challenge. I mean, that's remarkable. Terry Vik: That goes back to one of my longtime colleagues in Kenya, Festus Njuguna, who is Kenyan. He did his medical school training at Moi University and then did pediatric residency there. They call it a registrar program there. And then he was, since 2009, 2010, he's been the primary pediatric oncologist. Although he always felt he did not have the formal training. He'd spent time in the US and in Amsterdam to get some added training for caring for kids. But it was his vision to create this fellowship program. So Jodi Skiles, one of my colleagues who had spent some time in Kenya and myself and he worked on creating the fellowship document that needs to go through the university to get approved. That finally got approved in 2019. And so the first two fellows…I was on a Fulbright Scholar Award to start that fellowship program for a year right in the middle of the pandemic, but we were able to get it started, and I was able to continue to go back and forth to Kenya quite a bit in the last two years to get through all of the training that was laid out in our curriculum. And two fellows, Festus and another long-standing colleague of mine, Gilbert Olbara, both completed the fellowship and then sat for their final exams at the end of last year and graduated in December. So it really was heartwarming for me to see these guys want to build up the workforce capacity from within Kenya, and being able to support them to do that was a good thing. Pat Loehrer: Parenthetically, Dave, we had the first Gynecology Oncology program in the country, too, led by Barry Rosen from Princess Margaret, and they have 14 graduates, and two of them now are department chairs in Kenya. Jenny's spearheading a medical oncology curriculum now so that we have that opened up this year for the first time. Dave Johnson: It's uncommon to find a junior faculty as accomplished as Jenny. Jenny, tell us a little about your background and how you got interested in global health, and your previous work before moving to IU.  Jennifer Morgan: I was an anthropology major at undergrad at Michigan, and I think I really always liked studying other cultures, understanding different points of view. And so I think part of that spirit when you study anthropology, it really sticks with you, and you become a pretty good observer of people and situations, I think, or the goal is that you become good at it. I think my interest in medicine and science, combined with that desire to learn about different cultures really fueled a lot of my interests, even from undergrad and medical school. I really felt strongly that access to health is a human right, and I wanted to work for Partners in Health when I graduated from residency. I had heard a lot about that organization and really believed in the mission around it.   And so I went to work in Butaro in Rwanda, and I really didn't have any plans to do cancer care, but then I just kind of got thrown into cancer care, and I really loved it. It was a task-shifting model that really where you use internists to deliver oncology care under the supervision of oncologists from North America. So, most of them were from Dana-Farber or a variety of different universities. And so it made me feel like this high-resource field of Oncology was feasible, even when resources and health systems are strained. Because I think a lot of people who are interested in Oncology but also kind of this field of global health or working in underserved settings really struggle to find the way that the two fit sometimes because it can feel impossible with the hyper-expensive drugs, the small PFS benefits that drive the field sometimes. And so I think, Butaro for me, and Partners in Health, and DFCI, that whole group of people and the team there, I think, really showed me that it's feasible, it's possible, and that you can cure people of cancer even in small rural settings. And so that drove me to go to fellowship, to work with Satish Gopal and UNC. And because of COVID, my time in Malawi was a bit limited, but I still went and did mainly projects focused on breast cancer care and implementation science, and they just really have a really nice group of people. And I worked with Tamiwe Tomoka, Shakinah Elmore, Matthew Painschab, really just some great people there, and I learned a lot.  And so, when I was looking for a job after fellowship, I really wanted to focus on building health systems. And to me, that was really congruent with the mission of AMPATH, which is the tripartite mission of advancing education and research and clinical care. And I knew from Pat that the fellowship program would be starting off, and I think to me, having been in Rwanda and Malawi and realizing how essential building an oncology workforce is, being a part of helping build a fellowship as part of an academic partnership was really exciting. And then also doing very necessary clinical outcomes research and trying to do trials and trying to bring access to care in many systems that are very resource constrained. So that's kind of how I ended up here.  Pat Loehrer: That's awesome. So tell us a little bit about your breast cancer work. What exactly are you doing at the moment? Jennifer Morgan: In Malawi, during my fellowship, we looked at the outcomes of women with breast cancer and really looking at late-stage presentations and the fact that in Malawi, we were only equipped with surgery, chemotherapy, and hormone therapy, but not radiation. You see a lot of stage four disease, but you also see a lot of stage three disease that you actually have trouble curing because it's so locally advanced, really bulky disease. And so that first study showed us the challenge of trying to cure patients– They may not have metastatic disease, but it can be really hard to locally even treat the disease, especially without radiation. And so that's kind of what we learned.   And then, using an implementation science framework, we were looking at what are the barriers to accessing care. And I think it was really interesting some of the things that we found. In Malawi, that has a high HIV rate, is that the stigma around cancer can be far more powerful than the stigma around HIV. And so, we are seeing a lot of women who are ostracized by their communities when they were diagnosed with cancer. And really, they had been on, many HIV-positive women, on ARVs for a long time living in their communities with no problem, and so HIV had kind of been destigmatized, but we're seeing the stigma of cancer and the idea that kids are as a death sentence was a really prominent theme that we saw in Malawi.  So some of these themes, not all of them, but some of them are very similar in Kenya, and so what I'm helping work on now is there's been this huge effort with AMPATH called the Breast and Cervical Cancer Screening Program, where around 180,000 women have been screened for breast cancer in a decentralized setting which is so important - so in counties and in communities. We're looking at who showed up to this screening and why did women only get breast cancer screening and why did some of them only get cervical, and why did some get what was intended - both. Because I think many people on the continent and then other LMICs are trying to do breast and cervical cancer co-screening to really reduce the mortality of both of those cancers. And the question is, I think: is mammography a viable screening mechanism in this setting or not? That's a real question in Kenya right now. And so we're going to be looking to do some studies around mammography use and training as well.  Dave Johnson: So, I have a question for all three of you. What lessons have you learned in your work in Kenya or Malawi that you've brought back to the States to improve care in the United States? Pat Loehrer: One is that the cost of care is ever present there. And so one of the things that we need to think about here is how can we deliver care more cheaply and more efficiently. It goes against the drug trials that are going on by industry where they want to use therapy for as long as they can and for greater times. And there are a lot of common things like access to care is a big issue there, and it's a big issue in our country. So we have used in IU some community healthcare workers in rural parts of our state as well as in the urban centers so that they can go to people's houses to deliver care.  Terry was involved with a wonderful project. It was a supplement from the NCI, which looked at barriers to care and abandonment of therapy. And just by giving patients and their families a small stipend that would cover for their travel and their food, the abandonment rate went down substantially, and they were able to improve the cure rate of Burkitt's Lymphoma. It's probably about 60% now. And so those are issues that I think we see here in our state, where people can't come to IU because of the cost of parking, that's $20 a visit. The lesson there is that we really need to get down to the patients and to their families and find out what their obstacles are.  Terry Vik: My favorite example, since I deal with kids and parents, is how striking parents are the same worldwide. They all want the best for their child. They all want anything that can be done to potentially cure them, treatment, they do anything they could. And I think the hardest thing, as Pat said, is the financial burden of that care. And the other thing that I bring back to my fellows in the US is that you don't have to do Q4-hour or Q6-hour labs to follow somebody when they start their therapy. Once a day, every 3 days, works quite well also. And just the realization that things can be done with a lot less stress in the US if you only decide to do it. Dave Johnson: Jenny, any thoughts from you on that? Jennifer Morgan: I think for me, decentralized cancer care is so important. Even being back on the oncology wards in Indiana in December, I saw a couple of really advanced patients who were really unfortunate, and they had tried to go through the system of referrals and getting to cancer care. And unfortunately, I think there are disparities in the US health system, just like in Kenya, and maybe on different scales. But cancer care that's accessible is so important, and accessible versus available, I think we a lot of time talk about therapies that may be available, but they're not accessible to patients. And that's really what we see in Kenya, what we see in rural Indiana. There are a number of grants that talk about reciprocal innovation because some of these things that we do in Kenya to minimize burden on the system are things that can be done in rural Indiana as well. And so, partnership on these issues of trying to improve decentralized care is important everywhere.  Pat Loehrer: And again, from the perspective as a medical oncologist, we see patients with late-stage diseases. We could eradicate the number one cause of cancer in Sub-Saharan Africa, cervical cancer, from the face of the earth just by doing prevention. We don't do enough in our country about prevention. The other dimension I guess I wanted to bring up as far as multidisciplinary care - when we think about that in our country, it's radiation therapy, surgery, medical oncology, but one of the lessons learned there is that the fourth pillar is policy. It's really about cancer policy and working with the government, Ministry of Health to affect better insurance cover and better care and to work with a different discipline in terms of primary care, much more strongly than we do in our country.  Dave Johnson: Are you encountering similar levels of vaccine hesitancy in Kenya as you might see in the States, or is that something that's less of an issue? Pat Loehrer: I'll let Terry and Jenny answer that. Terry Vik: I think there is some degree of vaccine hesitancy, and not so much that it's fear of the vaccine, but it's fear of the people pushing the vaccine. If it's coming from the government or if it's coming from outside drug companies or outside physician recommendations, it's less likely to be taken up. And if it's coming from within their own community or if it's their chiefs and their community leaders they respected, then I think there is less vaccine hesitancy certainly in a lot of things we do in pediatrics. So I think there is hesitancy, but it's coming from a different source than what we see in the US.   Jennifer Morgan: I would agree, and I think also COVID has changed the game on vaccine perceptions everywhere, and I don't think Kenya is spared from that either. So it may take a few years to see really what's going on with that.   Pat Loehrer: Jenny and I were at this conference, it's a Cancer Summit in Nairobi a couple of weeks ago, and we saw this little documentary there. And this notion of misinformation, as we've seen in our country, is also common over there. They were interviewing a number of men and women from Northern Kenya about prostate cancer, which is a very serious problem in Kenya. The notion was that even doing PSA screening caused infertility, and so the men and women didn't want their husbands to get screened for prostate cancer because they would become less fertile by doing that. So, again, there are lessons that we– as Jenny mentioned from the top about anthropology, I think we're all connected, we all have different ways of viewing communications in health, but I do think that we can learn from each other substantially. Dave Johnson: I mean, it's remarkable work. How is it funded?  Pat Loehrer: Well, I've been fortunate to be able to work with some friends who are philanthropists. We've had strong support as we've told our story with various different foundations. And we've been very grateful to Pfizer, who are very helpful to us in the early stages of this - Lilly Foundation, Takeda, Celgene. And I think as we basically share our vision of what we're trying to accomplish, we've been very humbled by the support that we have gotten for us. The U54 helps support some of the research. We have D43 we're doing through Brown University. So we plan to increase our research funding as best as we can. But this is active generosity by some wonderful people. We have a $5.5 million cancer and chronic care building in which a large sum of it came from Indiana University and the Department of Radiation Oncology. Dr. Peter Johnstone helped lead that. There was a Lilly heir that gave us quite a bit of money. An Indian Kenyan named Chandaria also donated money. So it's a matter of presenting the vision and then looking for people that want to invest in this vision.  Well, I just want to say, from my perspective, I am more of a cheerleader than on the field. But Terry, I know you spent a tremendous amount of time on the ground in Kenya, and Jenny, you're living there. I just wanted to say publicly that you guys are my heroes. Dave Johnson: Yeah. I think all of our listeners will be impressed by what they heard today, and we very much appreciate you both taking time to chat with us.  So at this point, I want to thank our listeners of Oncology, Etc., an ASCO Educational Podcast. This is where we'll talk about oncology medicine and beyond. So if you have an idea for a topic or a guest you'd like us to interview, please email us at education@asco.org. To stay up to date with the latest episodes and explore other educational content, please visit education.asco.org.  Pat, before we go, I have an important question to ask you. Pat Loehrer: I can't wait. Dave Johnson: Do you know how snails travel by ship?  Pat Loehrer: As cargo! Dave Johnson: Awesome. You got it. All right. Well, Terry and Jenny, thank you so much for taking time to chat with us. It's been great. I'm very impressed with the work you guys are doing. Really appreciate your efforts. Terry Vik: Great. Thank you. Jennifer Morgan: Thank you. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.   Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

Join Val Saportas, CEO of Revvin, as we discuss the low code/no code phenomenon in application development. Find out what the hype is all about and why you should know something about this as you make the decision to purchase new software. Contact Val at valentin@revvin.com.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Make Believe Seattle is a genre film festival celebrating their inaugural year this weekend (March 23-26)! Thanks to Ted Geoghegan, I have the opportunity to cover six titles for this year's run, releasing the reviews as a miniseries on THE MOVIES. First up is the festival's Opening Night selection, Jake Van Wagoner's ALIENS ABDUCTED MY PARENTS AND NOW I FEEL KINDA LEFT OUT. Don't worry. It also took me a couple tries to say that title right out loud. The movie follows Itsy (Emma Tremblay), an aspiring teenage journalist frustrated by her family's move from the city to remote Utah town Pebble Falls, where the only kind of action comes in the form of snapping photos of dilapidated signs and cars. That is, until she meets Calvin Kipler (Jacob Buster), a classmate convinced his parents were abducted by aliens 10 years prior. I don't say "convinced" with the mental image of Charlie Kelly gesticulating wildly at a string-covered board. Calvin's made a full-blown spacesuit and wears it to school. He refers to people he trust as "friendlies." Star Trek's Vulcan "V" hand sign is not a pop culture gesture to him; it is intergalactic custom. This kid makes Randy Quaid from INDEPENDENCE DAY seem like Scully and Mulder. Seeing an opportunity to write a story about Calvin that'll win her a summer semester abroad at NYU, Itsy befriends the spaceman. At first, she focuses only on the story, but starts to warm up to Calvin, maybe moreso than expected. It's pretty easy for me to fall for Calvin too. Buster's performance is magnetic, drawing me and Itsy in with wit and goofball charm. As the story progresses, so does his emotional range, and I can attribute most of his moments that don't work to the strength of the screenplay/direction, which sometimes neuters the heavier portions of his story. However, this isn't a heavy movie. Calvin and Itsy's problems seem relatable enough even to young kids, and watching them fidget with and tweak gizmos inside Calvin's glorified shed of a research lab reminds me of the best times I spent dicking about trying to invent shit that would change the world (mainly a working web-shooter, but I digress). There's fun to be had and majesties to gawk at. After all, there's something about a night lit up with stars that seems not just ripe, but also infinite with possibility, with dreams. Does this thing suffer the effects of a limited budget? Yeah; any driving scene's got a rough green screen effect. Props often feel cobbled together from thrift shops and junkyards. Sometimes, the space VFX looks like something copied and pasted from After Effects, but when this stuff works, it's got an Amblin-inspired, DIY charm. What can I say? I like my sci-fi scrappy. Give it a watch! --------------------------- Closing Song: "Gimme Sympathy (Acoustic)" - Metric --------------------------- Review THE MOVIES on Apple Podcasts & I'll read it on the next episode! --------------------------- Follow Daniel on: Twitter - @TheMovies_Pod Instagram - @themoviespod Letterboxd - https://letterboxd.com/Daniel_Berrios/ --- Send in a voice message: https://podcasters.spotify.com/pod/show/themoviespodcast/message

Join Jeff Rose, President and CEO of American Bank and Trust, as we discuss the steps he took to hire an individual dedicated to digital strategy and then set the precedent that digital would be part of the bank's focus moving forward.  We discuss the role of the Chief Digital Officer, how it fits into traditional roles within the bank, challenges and successes that resulted from this decision.For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Join Stefan Jacewitz, Research and Policy Officer for the KC Federal Reserve Bank as we discuss the trends in savings rates and lending since the pandemic.  We know that the influx of cash into the economy boosted savings rates and lowered loan balances initially, but what has happened since then?  For more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Another in our 'Listed Lions' series - fan since 2004 Charlie Kelly.Would YOU like to be an Achtung Listed Lion? Or do you know someone who would? Hit us up at achtungmillwall@gmail.com of DM us at twitter @AchtungMillwallArrivederci MillwallNick Hosted on Acast. See acast.com/privacy for more information.

Ashley checks in with her friend Charlie Kelly about what they've both been watching this week for The Watch List and what queer TV & film characters inspired him, while sharing stories about being in the writer's room for The Great North. Meanwhile this episode's special guest star is comedian and writer Dan Perlman! Ashley's top TV recommendation this week is his show Flatbush Misdemeanors and you'll hear how the show came together, its Anti-Ted Lasso vibes and the two get nostalgic over Everybody Loves Raymond. Watch Flatbush Misdemeanors on Showtime now.Everything We Watched This Week!Victoria's Secrets: Angels and DemonsGrown-ishBelow Deck Sailing Yacht90 Day UK90 Day Fiancé90 Day Love in the CaribbeanDark Side of the 90sThe RehearsalHarley QuinnWhat We Do In The ShadowsMind Over MurderP-ValleyTuca and BertieLast Week Tonight w/ John OliverRap Sh**LootThe Bear Next Week's HomeworkPretty Little Liars: Original SinThe ResortReservation Dogs101 Places to Party Before You DieEverything's TrashHome EconomicsGrace and FrankieBlack Monday Wanna join TV Club? Get our official merch on Podswag or join our Patreon to tell Ashley what to watch!

The Always Sunny Casts official spaghetti policy is as follows, Spaghetti permitted.    Topics discussed in this episode include but are not limited to Jerry Corelli, getting to level 3, The Walking Dead trivia, surprise parties, spa-ghetti, the 3rd dimension, trip hop, stunt actors, cynicism, biplanes, how filthy Charlie is, scary racoons, first instincts, getting trapped like a RAAAAAA!, plastic walls, throwing coupons and dream books in the trash, and a couple different types of worm hats.   You are all invited to our underground luau.   P.S. Sorry this episode came out a few hours late, our computer exploded and a piece of screen hit Ross right in the dick, took it clean off.       

Wende Cragg has been a part of mountain biking since the beginning of the sport in California in the 1970s, racing and photographing the early Repack races down Mt. Tam. She was inducted into the mountain bike hall of fame in 1989 and curates the Rolling Dinosaur Archive which chronicles the birth of mountain biking. Tell us a bit about your introduction to mountain biking. Was it love at first ride? Which aspects of riding a bicycle off road were most appealing to you? How would you describe the feeling of those first rides? What was your motivation for taking photographs in the early days of mountain biking? What was it like connecting with riders in Crested Butte who were sorta discovering mountain biking in parallel with you and your friends in the Bay Area?How was their idea of mountain biking different from the one being developed in California? Were you surprised to see mountain bikers banned from riding on Mt. Tam in the early 80s? How did you react? Did you get frustrated with the early bikes?Do you think today's mountain bikes make the sport more appealing or accessible? How do electric mountain bikes fit in? What do you hope people get out of seeing and experiencing the Rolling Dinosaur Archive? With so many styles of riding within mountain biking today, which intepretation do you think gets closest to that original ethos? Photo: Rolling Dinosaur Archive Search the Singletracks podcast archive for interviews with more mountain bike pioneers including Joe Breeze, Gary Fisher, Charlie Kelly, and Tom Ritchey. ✏️ A written transcript of this conversation is available to Singletracks Pro supporters: singletracks.com/support --Keep up with the latest in mountain biking at Singletracks.com and on Instagram @singletracks --- Support this podcast: https://anchor.fm/singletracks/support

Yesterday, Cleveland Browns QB Baker Mayfield (and his dog) appeared on a podcast to air his grievances against the team that drafted him and still has yet to trade him. In the words of today's guest on this podcast, "shut up!"Charles Robinson is joined by NFL Network's Jim Trotter to talk about Baker's current sad state of affairs, what his current trade value appears to be and what the former first overall pick can to do save his spiraling career.Later, Charles & Jim look at Derek Carr's recent three-year extension with the Las Vegas Raiders. With many of the league's top QBs entering a $40 million per year average salary, is $50 million about to be the new $40 million? Also, despite this current spending spree, have the Raiders even made a dent in their ability to compete for a division title in the AFC West?Afterwards, the guys dive into the ongoing theory linking Tom Brady, the Miami Dolphins, Sean Payton & the Brian Flores lawsuit into a Charlie Kelly-like wall of yarn. As more pieces come together, is the NFL about to investigate itself in a circle proving multiple pieces of the Flores suit to be true?Finally, the guys spend the latter half the show discussing HBCUs and the NFL draft, why it's difficult for HBCU athletes to make the leap into the NFL, despite standouts like Darius Leonard & the many forces that continue to hold back black athletes and coaches from these schools.Please support Terez Paylor's legacy:• Buy an All-Juice Team hoodie or tee from BreakingT.com/Terez. All profits directly fund the Terez A. Paylor scholarship at Howard University.• Donate directly at giving.howard.edu/givenow. Under “Tribute,” please note that your gift is made in memory of Terez A. Paylor. Under “Designation,” click on “Other” and write in “Terez A. Paylor Scholarship.”• Donate directly to the PowerMizzou Journalism Alumni Scholarship in memory of Terez PaylorCheck out the rest of the Yahoo Sports podcast family at https://apple.co/3zEuTQj or at yahoosports.com/podcasts See acast.com/privacy for privacy and opt-out information.